Author Information

Danielle H. Tangorre

Danielle H. Tangorre, partner at Robinson+Cole, represents and advises a broad range of healthcare providers, including clinical laboratories and hospitals, on operational and compliance issues, federal and state fraud and abuse laws, other regulatory matters, and business transactions. Danielle completed a Clinical Ethics Fellowship at the Alden March Bioethics Institute at Albany Medical Center after obtaining an MS in Bioethics at Albany Medical Center, while concurrently completing law school at Albany Law School of Union University.

Posts by the Author

Compliance Perspectives-lca Enforcement-lca Essential Lab Industry Advisor Danielle H. Tangorre Seth B. Orkand

Staying on Top of Medical Necessity and Marketer Compliance

By Danielle H. Tangorre, Seth B. Orkand | Mar 25, 2024

Recent enforcement actions show that clinical laboratories must remain vigilant about compliance relating to these areas

iStock, Chor muang

Essential Lab Industry Advisor Labs in Court Seth B. Orkand Danielle H. Tangorre

February 2024 Labs in Court

By Seth B. Orkand, Danielle H. Tangorre | Jan 26, 2024

Recent cases show labs should be wary of issues such as improper relationships, medical necessity, kickbacks, and potential telehealth fraud.

Compliance-lca Essential Lab Compliance Advisor Danielle H. Tangorre

4 Things to Know About the End of the COVID-19 PHE

By Danielle H. Tangorre | May 31, 2023

The end of the COVID-19 public health emergency on May 11 also brings certain flexibilities for labs and other providers to an end.

Enforcement-nir Essential National Lab Reporter Danielle H. Tangorre

High Billing by Labs Continues to Be Trigger for Audits

By Danielle H. Tangorre | Feb 13, 2023

As we move further into 2023, COVID-19, add-on, and genetic tests will likely remain targets for federal regulators.

Coronavirus PCR Test istock

Log In

Join Now | Lost Password?